...

FREE SHIPPING ON U.S. ORDERS OVER $200

Sale!

DEtails:

Product Overview

TRZ-2 is a next-generation dual incretin peptide that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual-action mechanism sets it apart in metabolic research, where it has been extensively studied for its impact on weight management, blood glucose control, and metabolic efficiency.

Its ability to influence appetite signaling, insulin response, and fat metabolism has made Tirzepatide one of the most sought-after compounds in obesity, diabetes, and advanced metabolic research protocols.

Key Benefits & Research Applications

Dual Incretin Activation (GLP-1 + GIP): Studied for its unique ability to activate both incretin receptors, supporting enhanced glucose regulation, insulin sensitivity, and metabolic efficiency.
Weight Management & Appetite Control: Widely researched for reducing appetite, increasing satiety, and promoting significant body fat reduction in metabolic studies.
Metabolic Optimization: Investigated for improving glucose metabolism, lipid profiles, and overall energy balance.
Cardiometabolic Support: Utilized in research exploring cardiovascular health, insulin resistance, and long-term metabolic function.

Who Is This Research Compound For?

• Researchers studying weight loss and body composition
• Studies focused on insulin resistance and glucose control
• Investigations into metabolic syndrome and obesity
• Cardiometabolic and longevity-focused research models
• Advanced peptide users exploring cutting-edge incretin pathways

For Research Purposes Only

All products offered by Revive Peptides Co. are intended strictly for research and laboratory use only.
Not for human consumption.
Products are not intended to diagnose, treat, cure, or prevent any disease.

TRZ-2 | GLP-1 & GIP Dual Agonist, Metabolic & Weight Management

Price range: $89.00 through $204.00
Earn up to 204 points.

Related Products